GNTA Projected Dividend Yield
ADS (Sponsored)/Genenta Science SpA ( NASDAQ : GNTA )Genenta Science is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors. Co. has developed a biologic platform that involves the ex-vivo gene transfer of a therapeutic candidate into autologous hematopoietic stem or progenitor cells (HSPCs) to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes or macrophages (Tie2 Expressing Monocytes - TEMs). Co.'s technology is designed to turn TEMs into a "Trojan Horse" to counteract cancer progression and to prevent tumor relapse. 21 YEAR PERFORMANCE RESULTS |
GNTA Dividend History Detail GNTA Dividend News GNTA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |